BSX Q4 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.4B+9.9% YoY

Gross Profit

$1.6B66.8% margin

Operating Income

$444M18.4% margin

Net Income

-$615M-25.5% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$872M

Free Cash Flow

$793M

Stock-Based Comp.

$128M

Balance Sheet

Total Assets

$19.0B

Total Liabilities

$12.0B

Stockholders' Equity

$7.0B

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.2B	+9.9%
Gross Profit	$1.6B	$1.4B	+12.4%
Operating Income	$444M	$318M	+39.6%
Net Income	-$615M	$124M	-596.0%

Revenue Segments

MedSurg

$915M51%

Cardiovascular

$883M49%